
Keywords: C، مکمل; Adverse drug reactions; Complement; Pseudoallergy; Anaphylaxis; Anaphylatoxins; C5a; PigsANDA, abbreviated new drug application; C, complement; CARPA, C activation-related pseudoallergy; FDA, US Food and Drug Administration; EMA, European Medicine Agency;